Estudios

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2023; 401: 1499–507

Presentará el Dr. Esteban Romero

08 de noviembre 2023 16:00hrs / 17:15hrs

Kataoka K, Nishiyama O, Ogura T, et al. Long-term effect of pulmonary rehabilitation in idiopathic pulmonary fibrosis: a randomised controlled trial. Thorax 2023;78:784–791. Although pulmonary rehabilitation in patients taking nintedanib did not improve 6MWD in the long term, it led to prolonged improvement in endurance time.

Presenta Dra. Macarena Lagos

25 de octubre 2023 16:00hrs / 17:15hrs

Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea JAMA Cardiol. 2022;7(9):891-899. doi:10.1001/jamacardio.2022.1916

Presenta Dr. Francisco Gac

04 de octubre 2023 16:00hrs / 17:15hrs

William B. Feldman, MD, DPhil, MPH; Jerry Avorn, MD; Aaron S. Kesselheim, MD, JD, MPH; Joshua J. Gagne, PharmD, ScD. Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers. JAMA Internal Medicine July 2023 Volume 183, Number 7 CONCLUSION In this cohort study, LAMA-LABA therapy was associated with improved clinical outcomes compared with ICS-LABA therapy, suggesting that LAMA-LABA therapy should be preferred for patients with COPD

Presenta Dra. María José Correales

27 de septiembre 2023 16:00hrs / 17:15hrs

Evaluation of geriatric assessment and management on the toxic effects of cancer treatment. Lancet 2021; 398: 1894–904. Interpretation A geriatric assessment intervention for older patients with advanced cancer reduced serious toxic effects from cancer treatment. Geriatric assessment with management should be integrated into the clinical care of older patients with advanced cancer and ageing-related conditions.

Presenta Dr. Matías Ríos

13 de septiembre 2023 16:00hrs / 17:15hrs